Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association analysis for the muscarinic M1 receptor genetic polymorphisms and Alzheimer's disease.

Dementia and geriatric cognitive disorders - 1 Jan 2005

Liu Hsiu-Chih, Hong Chen-Jee, Liu Tsung-Yun, Chi Chin-Wen, Tsai Shih-Jen

Abstract excerpt

In the ongoing search to reveal the pathophysiology of Alzheimer's disease (AD), the cholinergic system is important due to its role in cognitive function and its significance with respect to the results of postmortem pathology and animal model studies. For this investigation, we tested the hypothesis that the allelic variant (C267A) of the cholinergic receptor muscarinic 1 (CHRM1) confers susceptibility to AD or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Disease Susceptibility

Share to Linkage Disequilibrium

Share to Neuropsychological Tests

Share to Receptors, Muscarinic

Share to Statistics as Topic

Source

Identifiers

PMID: 15383745
DOI: 10.1159/000080970

Genes

CHRM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association analysis for the muscarinic M1 receptor genetic polymorphisms and Alzheimer's disease.PMID 15383745Read ↗

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.Semantic proximity Read ↗

Association of Muscarinic M1 Receptor Genetic Polymorphisms with Psychiatric Symptoms and Cognitive Function in Schizophrenic PatientsSemantic proximity Read ↗

Functional screening of drug target genes: m1 muscarinic acetylcholine receptor phenotypes in degenerative dementias.Semantic proximity Read ↗

No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population.Semantic proximity Read ↗

APOE and APOC1 genetic polymorphisms in age-associated memory impairment.Semantic proximity Read ↗

Lack of association between CALHM1 p.P86L variation and Alzheimer's disease in the Han Chinese population.Semantic proximity Read ↗

Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.Semantic proximity Read ↗

No association between CALHM1 variation and risk of Alzheimer disease.Semantic proximity Read ↗

Muscarinic M1 receptor sequence: preliminary studies on its effects on cognition and expression.Semantic proximity Read ↗

Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease.Semantic proximity Read ↗

CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.Semantic proximity Read ↗

Single nucleotide polymorphisms of the human M1 muscarinic acetylcholine receptor gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.